Skip to main content
SpringerLink
Log in
Book cover

Lymphknotenerkrankungen im Kopf-Hals-Bereich pp 309–321Cite as

Maligne Lymphome

  • Chapter

Zusammenfassung

Maligne Lymphome stellen in der Regel generalisierte Erkrankungen dar, die sich nicht nur im lymphatischen System, sondern auch in anderen Organen manifestieren können. Eine sehr häufige Lokalisation der Erstmanifestation sind zervikale Lymphknoten.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abbondanzo SL, Wenig BM (1995) Non-Hodgkin’s lymphoma of the sinonasal tract. Cancer 75: 1281–1291

    Article  PubMed  CAS  Google Scholar 

  2. Armitage JO (1993) Treatment of non-Hodgkin’s lymphomas.N Engl J Med 328: 1023

    Article  PubMed  CAS  Google Scholar 

  3. Aviles A, Delgado S, Huerta-Huzman J (1996) Marginal zone B cell lymphoma of the parotid glands: Results of a randomised trial comparing radiotherapy to combined therapy. Oral Oncol Eur J Cancer 32B: 420–422

    Article  CAS  Google Scholar 

  4. Aviles A, Delgado S, Ruiz H et al. (1996) Treatment of Non-Hodgkin’s lymphoma of Waldeyer’s ring: Radiotherapy versus chemotherapy versus combined therapy. Oral Oncol Eur J Cancer 32B: 19–23

    Article  CAS  Google Scholar 

  5. Aydemir Ü, Dreyling M, Hölzel D (2000) Epidemiologie maligner Lymphome. In: Emmerich B (Hrsg) Maligne Lymphome: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Zuckschwerdt, München, S 1–8

    Google Scholar 

  6. Bayerdörffer E, Neubauer A, Rudolph B et al. (1995) Regression of primary lymphoma of mucosa-associated lymphoid tissue type after cure of helicobacter pylori infection. Lancet 345: 1591–1594

    Article  PubMed  Google Scholar 

  7. Beral V, Petermann T, Berkelmann R et al. (1991) AIDS-assos-ciated non-Hodgkin’s lymphoma. Lancet 337: 805

    Article  PubMed  CAS  Google Scholar 

  8. Brittinger G, Bartels H, Common H et al. (1986) Klinische und prognostische Relevanz der Kiel-Klassifikation der Non-Hodgkin-Lymphome. Onkologie 9: 118

    Article  PubMed  CAS  Google Scholar 

  9. Coiffier B, Lepage E, Herbrecht R et al. (2000) Mabthera (Rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): Interim results of a randomised GELA trial. Blood 96 (Suppl 11): 223a

    Google Scholar 

  10. Döhner H, Stilgenbauer S, Benner A et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910–1916

    Article  PubMed  Google Scholar 

  11. Dyer M (1999) The role of CAMPATH-1 antibodies in the treatment of lymphoid malignancies. Semin Oncol 5 (Suppl 14): 52–57

    Google Scholar 

  12. Fellbaum C, Hansmann M-L, Lennert K (1989) Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch A 414: 399–405

    Article  CAS  Google Scholar 

  13. Fisher RI, Gaynor ER, Dahlberg S et al. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328: 1002

    Article  PubMed  CAS  Google Scholar 

  14. Gospodarowicz MK, Sutcliffe SB, Brown et al. (1987) Patterns of disease in localised extranodal lymphoma. J Clin Oncol 5: 875–880

    PubMed  CAS  Google Scholar 

  15. Hallek M, Langenmayer I,Nerl C et al. (1999) Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukaemia. Blood 93: 1732–1737

    PubMed  CAS  Google Scholar 

  16. Harris NL, Jaffe ES, Stein H et al. (1994) A revised European American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study group. Blood 84: 1361–1392

    PubMed  CAS  Google Scholar 

  17. Harris NL, Jaffe ES, Diebold J et al. (1999) World Health Organisation Classification of neoplastic dieseases of the hematopoetic and lymphoid tissues; report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835–3849

    PubMed  CAS  Google Scholar 

  18. Hiddemann W, Unterhalt M, Sack H (1997) Aktueller Stand in der Therapie von follikulären Keimzentrumslympho-men und Mantelzell-Lymphomen. Internist 2: 122–134

    Google Scholar 

  19. Hiddemann W, Unterhalt M (1998) Stand und Perspektiven in der Therapie follikulärer Keimzentrumslymphome. Dtsch Ärztebl 95: A3209–A3216

    Google Scholar 

  20. Hirokawa N, Hareyama M, Akiba H et al. (1998) Diagnosis and treatment of malignant lymphoma of the parotid gland. Jpn J Clin Oncol 28: 245–249

    Article  PubMed  CAS  Google Scholar 

  21. Hoppe RT, Burke JS, Glatsein E et al. (1978) Non-Hodgkin’s lymphoma: Involvement of Waldeyer’s ring. Cancer 42: 1096–1104

    Article  PubMed  CAS  Google Scholar 

  22. Horning SJ, Rosenberg S (1984) The natural history of initially untreated low-grade Non-Hodgkin’s lymphomas. N Engl J Med 311: 1471–1475

    Article  PubMed  CAS  Google Scholar 

  23. Hudson BV, Hudson GV, Mac Lennan KA et al. (1994) Clinical stage I non-Hodgkin’s lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 69: 1088

    Article  Google Scholar 

  24. Hyjek E, Smith WJ, Isaaacson PG (1988) Primary B cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 19: 766–776

    Article  PubMed  CAS  Google Scholar 

  25. Jacobs C, Hoppe RT (1985) Non-Hodgkin’s lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 11: 357–364

    Article  PubMed  CAS  Google Scholar 

  26. Josting A, Diehl V, Engert A (2000) Behandlung und Prognose primär progredienter und rezidiverter Hodgkin-Lymphome. Onkologe 6: 1178–1188

    Article  Google Scholar 

  27. Kaiser U, Trümper L, Pfreundschuh M, Havemann K (1997) Therapie hochmaligner Non Hodgkin Lymphome. Internist 38: 135–142

    PubMed  CAS  Google Scholar 

  28. Kassan SS, Thomas TL, Moutsopoulos HM et al. (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89: 888–892

    PubMed  CAS  Google Scholar 

  29. Küppers R, Rajewski K (1998) The origin of Hodgkin and reed/Sternberg cells in Hodgkin’s disease. Annu Rev Immunol 16: 471–493

    Article  PubMed  Google Scholar 

  30. Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. Springer, New York

    Book  Google Scholar 

  31. Liang R, Todd D, Chan TK (1995) Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 13: 666–667

    PubMed  CAS  Google Scholar 

  32. Logsdon MD, Ha CS, Kavadi VS et al. (1997) Lymphoma of the nasal cavity and paranasal sinuses. Cancer 80: 477–488

    Article  PubMed  CAS  Google Scholar 

  33. Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26: 1063–1081

    PubMed  CAS  Google Scholar 

  34. McKelvey EM, Gottlieb JA, Wilson HE (1976) Hydroxy-dau-nomycin (adriamycin) combination chemotherapy in malignant lymphomas. Cancer 38: 1484

    Article  PubMed  CAS  Google Scholar 

  35. Musshoff K (1977) Klinische Stadieneinteilung der Nicht-Hodgkin Lymphome. Strahlentherapie 153: 218–221

    PubMed  CAS  Google Scholar 

  36. Persson B, Frederikson M (1999) Some risk factors for non-Hodgkin’s lymphoma. Int J Occup Med Environ Health 12: 135–142

    PubMed  CAS  Google Scholar 

  37. Philip T, Gugliemi C, Hagenbeck A et al. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive NHL. N Engl J Med 333: 1540–1545

    Article  PubMed  CAS  Google Scholar 

  38. Sasai K, Yamabe H, Kokubo M et al. (2000) Head and neck stages I and II extranodal non-Hodgkin’s lymphomas: REAL classfication and selection for treatment modalities. Int J Rad Oncol Biol Phys 48: 153–160

    Article  CAS  Google Scholar 

  39. Shibuya H, Kamiyama R-I, Watanabe I et al. (1978) Stage I and II Waldeyer’s ring and oral-sinonasal non-Hodgkin’s lymphoma. Cancer 59: 940–944

    Article  Google Scholar 

  40. Staar S, Müller RP (2000) Von der extended-field zur involved field Radiotherapie des Morbus Hodgkin in frühen Stadien. Onkologe 6: 1160–1168

    Article  Google Scholar 

  41. Takahashi H, Cheng J, Fujita S et al. (1992) Primary malignant lymphoma of the salivary gland: A tumor of mucosaassociated lymphoid tissue. J Oral Pathol Med 21: 318–325

    Article  PubMed  CAS  Google Scholar 

  42. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project, Shipp MA, Harrington DP, Anderson JR, Armitage JO, Bonadonna G, Brittinger G (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329: 987

    Article  Google Scholar 

  43. Van Prooyen Keyzer S, Eloy P, Delos M et al. (2000) Sinonasal lymphomas. Acta Otorhinolaryngol Belg 54: 45–51

    Google Scholar 

  44. Van Besien KW, Mehra RC, Giralt SA et al. (1996) Allogenic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology. Am J Med 100: 299

    Article  PubMed  Google Scholar 

  45. Wolf J, Franklin J, Diehl V (2000) Primärtherapie des Morbus Hodgkin. Neue Strategien für den Einsatz der Chemotherapie. Onkologe 5: 1169–1177

    Article  Google Scholar 

  46. Xe-Xiong L, Couke P, Jian-Ying L et al. (1998) Primary non-Hodgkin’s lymphoma of the nasal cavity. Cancer 83: 449–456

    Article  Google Scholar 

  47. Yuen A, Jacobs C (1999) Lymphomas of the head and neck. Semin Oncol 26: 338–345

    PubMed  CAS  Google Scholar 

  48. Zeeb H, Blettner M (2001) Steigende Inzidenz und Mortalität der Non-Hodgkin Lymphome. Med Klin 96: 87–100

    Article  CAS  Google Scholar 

  49. Zucca E, Roggero E, Bertoni F et al. (1999) Primary extranodal non-Hodgkin’s lymphomas. Head and neck, central nervous system and other less common sites. Ann Oncol 10: 1023–1033

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. U. Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Neubauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kaiser, U., Neubauer, A. (2002). Maligne Lymphome. In: Lymphknotenerkrankungen im Kopf-Hals-Bereich. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55923-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55923-5_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43032-2

  • Online ISBN: 978-3-642-55923-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation